A PHASE-II STUDY OF THE RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) FOLLOWING CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) CHEMOTHERAPY IN PATIENTSWITH SMALL-CELL LUNG-CANCER (SCLC)

Authors
KUDO S KURIHARA N FURUSE K KURITA Y FUKUOKA M TAKADA M TAKAKU F OGAWA M ARIYOSHI Y
Citation
S. Kudo et al., A PHASE-II STUDY OF THE RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) FOLLOWING CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) CHEMOTHERAPY IN PATIENTSWITH SMALL-CELL LUNG-CANCER (SCLC), European journal of cancer, 31A, 1995, pp. 243-243
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
31A
Year of publication
1995
Supplement
5
Pages
243 - 243
Database
ISI
SICI code
0959-8049(1995)31A:<243:APSOTR>2.0.ZU;2-#